Switzerland· 66748001
Aimovig 70 mg/ml, Injektionslösung im Fertigpen
A erenumab product, registered in Switzerland by Novartis Pharma Schweiz AG and dispensed under Swissmedic category B. The same ATC class is registered in 13 of our 19 countries.
Checked against the register on
Informational only — not a medical device.
Where it is registered
Erenumab is registered in 13 of 19 countries.
Countries holding a registration under ATC N02CD01 (erenumab), each read from that country’s own register.
- This record: Switzerland
- 9 of them publish a price we can compare per daily dose
Erenumab · ATC N02CD01
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
- Manufacturer
- Novartis Pharma Schweiz AG
- Country
- Switzerland (CH)
- ATC code
- N02CD01
- ATC class
- Erenumab
- Defined daily dose
- 2.5 mg, P
- Swissmedic category
- B
- Reimbursed
- No
- Last checked
- June 26, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under N02CD01
Erenumab, as other registers publish it.
- IcelandAimovigNovartis Europharm Limited*
- FinlandAimovigNovartis Europharm Limited
- PolandAimovigNovartis Europharm Limited
- DenmarkAimovigNovartis Europharm Limited
- FinlandAimovigNovartis Europharm Limited
- FinlandAimovigOrifarm Oy
- PolandAimovigNovartis Europharm Limited
- IcelandAimovigNovartis Europharm Limited*
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c887d8f6-d9aa-45fd-a77f-4cd524ba1060 GET /v1/drugs/c887d8f6-d9aa-45fd-a77f-4cd524ba1060?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "swissmedic_auth",
"heilmittelcode": "Biotechnologika"
}See everything about erenumab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.